ad image

Finance

1 / 2
CRB
Business Leadership

CRB Names Experienced Business Leader as CFO

CRB

PR-M01-22-04Jan 05, 2022
AbbVie Issues Large Bond to Finance Allergan Merger
M&A

AbbVie Issues Large Bond to Finance Allergan Merger

Nice Insight

PAO-M11-19-NI-006Nov 12, 2019
BridgeBio Pharma
IPO

BridgeBio Pharma Announces Pricing of Its Initial Public Offering

BridgeBio Pharma

PR-M06-19-NI-060Jun 28, 2019
Whole Biome Raises $35 Million in Series B Financing
Series B Financing

Whole Biome Raises $35 Million in Series B Financing

Emilie Branch

Pharma's Almanac

PAO-M06-19-NI-002Jun 13, 2019
Thrive Earlier Detection Gets Funding from Third Rock to Develop Cancer Detection Tech
Financing

Thrive Earlier Detection Gets Funding from Third Rock to Develop Cancer Detection Tech

Pharma's Almanac

PAO-M06-19-NI-001Jun 13, 2019
SAGA Diagnostics
Finance

SAGA Raises 40 Million SEK (€3.7 Million) to Advance Ultrasensitive Cancer Liquid Biopsies

SAGA Diagnostics

PR-M06-19-NI-009Jun 12, 2019
Boehringer Ingelheim Investing in Mexico
Investment

Boehringer Ingelheim Investing in Mexico

Nice Insight

PAO-M05-19-NI-033May 31, 2019
Syncona Ltd
Series A Financing

Syncona founds Quell Therapeutics with £35 million Series A Financing

Syncona Ltd

PR-M05-19-NI-063May 22, 2019
Schrödinger
Financing

Schrödinger Announces Close of Latest Financing, Raising a Total of $110 Million

Schrödinger

PR-M05-19-NI-062May 22, 2019
Nestle Health Science
Announcement

Nestlé Enters into Exclusive Negotiations to Sell Nestlé Skin Health to a Consortium Led by EQT and ADIA

Nestle Health Science

PR-M05-19-NI-053May 17, 2019
KNOW Bio, LLC
Financing

KNOW Bio Announces Closing of $30 Million in Equity Financing

KNOW Bio, LLC

PR-M05-19-NI-048May 16, 2019
Fengate
Investment

Fengate Exceeds Fundraising Target and Closes Core Infrastructure Fund III with $1.1 Billion in Capital Commitments

Fengate

PR-M05-19-NI-046May 16, 2019
Gene Therapy Costs Discussed by Insurance Company Heads
Drug Pricing

Gene Therapy Costs Discussed by Insurance Company Heads

Emilie Branch

Pharma's Almanac

PAO-M05-19-NI-010May 10, 2019
KIYATEC, Inc.
Financing

KIYATEC Announces $3 Million Initial Closing of Series B2 Preferred Stock Financing and New Investor LabCorp

KIYATEC, Inc.

PR-M05-19-NI-031May 10, 2019
Invitae
Earnings

Invitae Reports 47% Growth in Quarterly Revenue and Volume Year-Over-Year

Invitae

PR-M05-19-NI-026May 09, 2019
Insulet Reports First Quarter 2019 Revenue of $159.6 Million, an Increase of 29% Year-Over-Year
Earnings

Insulet Reports First Quarter 2019 Revenue of $159.6 Million, an Increase of 29% Year-Over-Year

Nice Insight

PR-M05-19-NI-021May 07, 2019
Sirnaomics, Inc.
Series C Financing

Sirnaomics Closes $47 Million Series C Financing to Develop RNAi Therapeutics for Treatment of Cancer and Fibrotic Diseases

Sirnaomics, Inc.

PR-M04-19-NI-091Apr 30, 2019
Perrigo
Finance

Perrigo Increases Its Dividend By 11%

Perrigo

PR-M04-19-NI-090Apr 30, 2019
Pharma Company Tax Savings Went to Investors and Stock Buybacks
Finance

Pharma Company Tax Savings Went to Investors and Stock Buybacks

Nice Insight

PAO-M04-19-NI-017Apr 18, 2019
WuXi Biologics
Finance

WuXi Biologics Continues to Deliver Record Results

WuXi Biologics

PR-M03-19-NI-052Mar 19, 2019
1 / 2